These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 737983)

  • 21. Phase II study of high-dose amsacrine (AMSA) and autologous bone marrow transplantation in patients with refractory metastatic breast cancer.
    Tannir N; Spitzer G; Schell F; Legha S; Zander A; Blumenschein G
    Cancer Treat Rep; 1983 Jun; 67(6):599-600. PubMed ID: 6344995
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapy of advanced gastrointestinal cancer with the nitrosoureas.
    Moertel CG
    Cancer Chemother Rep 3; 1973 May; 4(3):27-34. PubMed ID: 4748872
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cytostatic treatment of metastasizing breast cancer. A prospective controlled comparison between single drug and multiple drug chemotherapy].
    Mouridsen HT; Palshof T; Brahm M; Rahbek I
    Ugeskr Laeger; 1977 Oct; 139(44):2632-5. PubMed ID: 929742
    [No Abstract]   [Full Text] [Related]  

  • 24. A clinical evaluation of a prolonged schedule of cytosine arabinoside (NSC63878).
    Burke PJ; Owens AH; Colsky J; Shnider BI; Edmonson JH; Schilling A; Brodovsky HS; Wallace HJ; Hall TC
    Cancer Res; 1970 May; 30(5):1512-5. PubMed ID: 5426952
    [No Abstract]   [Full Text] [Related]  

  • 25. [Combined chemo-radiotherapeutic treatment of breast neoplasms at the metastatis stage].
    Agati G; Stoppa IM
    J Radiol Electrol Med Nucl; 1967 Nov; 48(11):803-4. PubMed ID: 5591688
    [No Abstract]   [Full Text] [Related]  

  • 26. [Granulocyte under conditions of altered equilibrium induced with endotoxins].
    Mela GS; Bianco B; Ridella S; Sacchetti C
    Boll Soc Ital Biol Sper; 1973 Oct; 49(20):1173-9. PubMed ID: 4802233
    [No Abstract]   [Full Text] [Related]  

  • 27. The leucocyte nadir, a predictor of chemotherapy efficacy?
    Kvinnsland S
    Br J Cancer; 1999 Aug; 80(11):1681. PubMed ID: 10468282
    [No Abstract]   [Full Text] [Related]  

  • 28. [Letter: Bone Marrow localization of Hodgkin's disease. Combination drug therapy].
    Fière D; Bryon PA
    Nouv Presse Med; 1975 Mar; 4(9):671. PubMed ID: 1129135
    [No Abstract]   [Full Text] [Related]  

  • 29. Chemotherapy of differentiated thyroid carcinomas. Clinical results and effects on the granulocytic stem cell (CFUc) compartment.
    Droz JP; Morardet N; Charbord P; Maraninchi D; Hayat M; Parmentier C
    Ann Radiol (Paris); 1977; 20(8):814-8. PubMed ID: 610554
    [No Abstract]   [Full Text] [Related]  

  • 30. [Action of levamisole on bone marrow repair in patients undergoing anticancer chemotherapy].
    Dujardin P; Lods JC; Cassuto JP; Audoly P
    Therapie; 1976; 31(6):733-8. PubMed ID: 1025779
    [No Abstract]   [Full Text] [Related]  

  • 31. Nephrotic-range proteinuria following pamidronate therapy in a patient with metastatic breast cancer: mitochondrial toxicity as a pathogenetic concept?
    Sauter M; Jülg B; Porubsky S; Cohen C; Fischereder M; Sitter T; Schlondorff D; Gröne HJ
    Am J Kidney Dis; 2006 Jun; 47(6):1075-80. PubMed ID: 16731304
    [No Abstract]   [Full Text] [Related]  

  • 32. Chemotherapy of solid tumors.
    Petersen M; Taylor JD
    Med J Aust; 1978 Mar; 1(6):340. PubMed ID: 661705
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cytostatic therapy of metastasizing breast cancer].
    Schmidt G; Pittner W
    Z Allgemeinmed; 1973 Dec; 49(34):1690-2. PubMed ID: 4207852
    [No Abstract]   [Full Text] [Related]  

  • 34. Bisphosphonates for breast cancer: questions answered, questions remaining.
    Layman R; Olson K; Van Poznak C
    Hematol Oncol Clin North Am; 2007 Apr; 21(2):341-67. PubMed ID: 17512453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [History and significance to giant cells caused by mitosis inhibition].
    Marinone G; Baserga A
    Minerva Med; 1975 Jul; 66(49):2367-77. PubMed ID: 1056511
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of local and regional breast cancer: chemotherapy].
    Moreno Nogueira JA
    Rev Esp Oncol; 1980; 27(1):129-47. PubMed ID: 7209104
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experiences with cytostatic combination therapy in hormone-resistant metastasizing breast cancer].
    Brunner KW
    Schweiz Med Wochenschr; 1969 Sep; 99(36):1298-303. PubMed ID: 5351150
    [No Abstract]   [Full Text] [Related]  

  • 38. [Stem cell kinetics of bone marrow in relation to cytostatic treatment].
    Laerum OD
    Tidsskr Nor Laegeforen; 1971 Jun; 91(16):1207-9 passim. PubMed ID: 4935674
    [No Abstract]   [Full Text] [Related]  

  • 39. [Our experiences with the chemotherapy of metastazing breast cancer].
    Riedler L
    Z Allgemeinmed; 1975 Oct; 51(28):1234-6. PubMed ID: 1199144
    [No Abstract]   [Full Text] [Related]  

  • 40. [Characterization of functional disorders of bone marrow by measuring chemiluminescence].
    Reinhardt U; Reinhardt U; Rudolph E; Fleischer J
    Z Gesamte Inn Med; 1987 Jun; 42(12):341-3. PubMed ID: 3630280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.